ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings Inc (RVPH)

1,88
0,01
(0,53%)
Fermé 11 Janvier 10:00PM
1,8605
-0,0195
(-1,04%)
Après les heures de négociation: 1:55AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,8605
Prix Achat
1,86
Prix Vente
1,88
Volume échangé
4 438 288
1,85 Fourchette du Jour 2,12
0,60 Plage de 52 semaines 4,83
Cap du marché
Clôture Veille
1,87
Ouverture
1,97
Dernière Transaction
1
@
1.8793
Dernière heure de transaction
Volume financier
US$ 8 717 524
VWAP
1,9642
Volume moyen (3 m)
2 580 170
Actions en circulation
33 441 199
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-7,45
Bénéfice par action (BPA)
-1,17
Chiffre d'affairess
-
Bénéfice net
-39,26M

À propos de Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the dev... Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis. Show more

Secteur
Blank Checks
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
2018
Reviva Pharmaceuticals Holdings Inc est coté dans le secteur Blank Checks de la NASDAQ avec le ticker RVPH. Le dernier cours de clôture d'Reviva Pharmaceuticals était de US$1,87. Au cours de la dernière année, les actions de Reviva Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,60 à US$ 4,83.

Reviva Pharmaceuticals compte actuellement 33 441 199 actions en circulation. La capitalisation boursière d'Reviva Pharmaceuticals est de US$62,54 million. Reviva Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -7.45.

Flux d'options Reviva Pharmaceuticals (RVPH)

Flux global

Baissier

Prime nette

-29k

Calls / Puts

0,00%

Ach. / Vent.

100,00%

OTM / ITM

0,00%

Sweeps Ratio

0,00%

RVPH Dernières nouvelles

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1295-6.507537688441.992.171.789934568871.94943591CS
4-1.0695-36.50170648462.932.951.2348155171.77734196CS
120.580545.35156251.284.280.88225801701.85593633CS
260.640552.51.224.280.613984171.72310357CS
52-2.4395-56.73255813954.34.830.68548761.9245277CS
156-1.6795-47.44350282493.549.24990.536612322.83687165CS
260-7.5995-80.33298097259.469.610.535983803.7603298CS

RVPH - Frequently Asked Questions (FAQ)

What is the current Reviva Pharmaceuticals share price?
The current share price of Reviva Pharmaceuticals is US$ 1,8605
How many Reviva Pharmaceuticals shares are in issue?
Reviva Pharmaceuticals has 33 441 199 shares in issue
What is the market cap of Reviva Pharmaceuticals?
The market capitalisation of Reviva Pharmaceuticals is USD 62,54M
What is the 1 year trading range for Reviva Pharmaceuticals share price?
Reviva Pharmaceuticals has traded in the range of US$ 0,60 to US$ 4,83 during the past year
What is the PE ratio of Reviva Pharmaceuticals?
The price to earnings ratio of Reviva Pharmaceuticals is -7,45
What is the reporting currency for Reviva Pharmaceuticals?
Reviva Pharmaceuticals reports financial results in USD
What is the latest annual profit for Reviva Pharmaceuticals?
The latest annual profit of Reviva Pharmaceuticals is USD -39,26M
What is the registered address of Reviva Pharmaceuticals?
The registered address for Reviva Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Reviva Pharmaceuticals website address?
The website address for Reviva Pharmaceuticals is revivapharma.com
Which industry sector does Reviva Pharmaceuticals operate in?
Reviva Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
VRMEVerifyMe Inc
US$ 2,57
(52,98%)
57,83M
WKEYWISeKey International Holdings AG
US$ 10,041
(52,83%)
6,72M
DATSDatChat Inc
US$ 4,8105
(49,86%)
158,65M
CDTConduit Pharmaceuticals Inc
US$ 0,1214
(48,05%)
1,17B
INTZIntrusion Inc
US$ 2,8888
(44,44%)
40,61M
IGMSIGM Biosciences Inc
US$ 2,095
(-66,21%)
5,81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1,87
(-51,30%)
2,28M
MODVModivCare Inc
US$ 6,51
(-47,88%)
2,73M
AIFUAIX Inc
US$ 0,420501
(-47,76%)
7,85M
MRSNMersana Therapeutics Inc
US$ 0,691
(-46,85%)
58,44M
CDTConduit Pharmaceuticals Inc
US$ 0,1214
(48,05%)
1,16B
NVDANVIDIA Corporation
US$ 135,91
(-3,00%)
203,27M
RGTIRigetti Computing Inc
US$ 8,9299
(-11,06%)
175,21M
VMARVision Marine Technologies Inc
US$ 2,14
(40,79%)
174,99M
DATSDatChat Inc
US$ 4,8105
(49,86%)
158,56M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock